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Abstract
Background: Arsenic is a carcinogen that is known to induce cell transformation and tumor
formation. Although studies have been performed to examine the modulation of signaling
molecules caused by arsenic exposure, the molecular mechanisms by which arsenic causes cancer
are still unclear. We hypothesized that arsenic alters gene expression leading to carcinogenesis in
the lung.
Results: In this study, we examined global gene expression in response to 0.75 µM arsenic
treatment for 1–7 days in a rat lung epithelial cell line (L2) using an in-house 10 k rat DNA
microarray. One hundred thirty one genes were identified using the one-class statistical analysis of
microarray (SAM) test. Of them, 33 genes had a fold change of ≥ 2 between at least two time points.
These genes were then clustered into 5 groups using K-means cluster analysis based on their
expression patterns. Seven selected genes, all associated with cancer, were confirmed by real-time
PCR. These genes have functions directly or indirectly related to metabolism, glycolysis, cell
proliferation and differentiation, and regulation of transcription.
Conclusion: Our findings provide important insight for the future studies of arsenic-mediated lung
cancer.
Background
Arsenic is a carcinogen that causes lung cancer as well as
skin, bladder and kidney cancers [1]. At 50 µg/liter, the
cancer risk to people caused by arsenic has been estimated
to be between 1300 to 1650 per 100,000 people [2]. The
identification of the chemical species that are active toxi-
cants and the mode of toxicity are both important compo-
nents for accurately determining the full breadth of
arsenic exposure.
Several mechanisms for arsenic-induced carcinogenesis
have been proposed including genetic and epigenetic
changes, inhibition of DNA repair, oxidative stress, altera-
tions in cell death and proliferation, and aberrant activa-
tion of signal transduction pathways [3]. Exposure of TM3
testicular Leydig cells to arsenic results in the changes in
DNA methylation and mutations as determined by ran-
dom amplified polymorphic DNA (RAPD) [4]. Arsenic
exposure reduces DNA repair probably by inhibiting DNA
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repair proteins such as excision repair cross-complement
1 (ERCC1) and zinc fingers DNA repair proteins [5,6].
Arsenic also alters cell-cycle related genes including cyclin
D1, and cdc25A, and thus cell proliferation [7-9].
Arsenic-related gene expression studies have been per-
formed in several different cell types [7,10,11]. Interest-
ingly, genes involved with cellular respiration have been
consistently identified in these expression studies. The
addition of arsenite to human keratinocytes has been
shown to lead to an increase in thioredoxin reductase
(TrxR), a selenocysteine isomer involved in many cellular
redox processes that is often up-regulated in cancers [12].
The same study reported that glutathione peroxidase (Gpx),
which protects against reactive oxygen species (ROS), was
reduced in expression upon the arsenic exposure [12].
This implies that arsenic exposure not only promotes the
production of ROS but also reduces the cell's ability to
defend against ROS. This is a notable concept, considering
that ROS have long been known to contribute to carcino-
genesis [13,14].
Arsenic activates all mitogen-activated protein kinase
(MAPK) pathways, including the extracellular signal regu-
lated protein kinase (ERK), c-Jun N-terminal kinase (JNK)
and p38 kinase [15-17]. MAPK pathways are involved in
cell proliferation and apoptosis. ERK activation by arsenic
results in cell proliferation while JNK activation induces
apoptosis. Arsenic likely activates these pathways via tyro-
sine kinase receptors such as the EGF receptor. In addition
to activating kinases, arsenic is also known to regulate
transcription factors including AP-1  [18-20] and NFkB
[21-23]. These findings strongly suggest that arsenic is
involved in the disturbance of the regulation of these
pathways, which may lead to cancer.
We hypothesized that arsenic alters gene expression in the
lung and that the alterations lead to carcinogenesis by
direct and indirect means. We examined global gene
expression in an arsenic-treated rat lung epithelial cell line
(L2) using an in-house 10 k rat DNA microarray. The
microarray data was confirmed using real-time PCR anal-
ysis of selected up- or down-regulated genes. Taken
together, this study provides a valuable baseboard for the
future study of arsenic-induced cell transformation.
Results
Cell viability after arsenic exposure
We first determined the viability of the L2 cells treated
with arsenic in order to optimize our further experiments.
When grown to 80 to 90% confluence, the cells were
treated for 7 days with sodium arsenite with (0–5 µM).
The cell viability was significantly reduced at >1 µM of
arsenite as determined by the MTT assay (Fig. 1). Based on
the results, we chose the following conditions for micro-
array experiments: 0.75 µM for 1, 3, 5 and 7 days.
Microarray data analysis following arsenic exposure
We treated L2 cells with 0.75 µM of arsenite for the
assigned time periods and subsequently performed DNA
microarray analysis of 10 k genes in order to determine
changes in the gene expression that may be cancer-related.
The samples were arranged for hybridization using a loop
design (Fig. 2A). For each paired sample, dye flip was used
to overcome the difference between two fluorescent dyes
(Fig. 2B). There were a total of 30 hybridizations (3 cell
preparations, dye flip, and 5 samples). 131 genes (100
known genes and 31 EST) passed the statistical analysis of
microarray (SAM) test (P < 0.05) (see Additional file 1).
Of them, 33 genes had a fold change of ≥ 2 between at
least two time points. These genes would be the starting
point for our study of possible carcinogenic pathways.
Cluster analysis and major functional categories
Following identification, we used K-means cluster analy-
sis to cluster the 131 genes into 2–10 nodes. We found
that 5 nodes or 5 clusters best represented their patterns of
expression (Fig. 3). Of these genes, 78 were annotated by
gene ontology [24], which described the genes in terms of
their biological processes, cellular components and
molecular functions in a species-independent manner.
The functions of the clusters included: cell adhesion,
Viability of L2 cells treated with arsenic Figure 1
Viability of L2 cells treated with arsenic. L2 cells were 
cultured in 30 mm cell culture dishes in F12 K medium sup-
plemented with 10% of fetal bovine serum. When grown to 
80 to 90% confluence, the cells were treated for 7 days with 
sodium arsenite (0–5 µM). The cell viability was significantly 
reduced at >1 µM of arsenite as determined using MTT 
assay. The results were expressed as a percentage of control 
(untreated cells). Data shown are means ± S.E. (n = 3 cell 
preparations).BMC Genomics 2008, 9:115 http://www.biomedcentral.com/1471-2164/9/115
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metabolism, development, response to injury, transport,
cell motility, glycolysis, cell differentiation, cell cycle, sig-
naling, regulation of transcription, cell proliferation, pro-
teolysis and peptidolysis (Fig. 4).
Cluster 1 (11 genes) decreased in expression on day 1 and
increased on day 3 and then declined in expression on
days 5 and 7. Cluster 1 is composed largely of cellular
response and development. Cluster 2 (13 genes) increased
in expression on day 1 and declined fairly steadily there-
after. Cluster 2 involves regulation of transcription, sign-
aling, transport and response to cellular injury. Cluster 3
(36 genes) tended to gradually increase in expression con-
tinuously from day 0 to day 7. Cluster 4 (28 genes) had
high expression on days 3 and 7. Cluster 4 is composed of
a fairly even mixture of the functional categories stated.
Cluster 5 (43 genes) steadily decreased in expression from
day 0 to day 7. Fold changes in each cluster were lower
than 2 (Fig. 4). This is because the values were the averages
of all genes in each cluster. Of 11, 13, 36, 28 and 43 genes
in clusters 1–5, only 4, 5, 5, 9, 10 genes in clusters 1–5 had
a fold change of ≥ 2 between two time points. The tempo-
ral differences in the expression of these gene clusters pro-
vide a clue as to how these genes may participate in the
process of arsenic-mediated cell toxicity.
Real-time PCR confirmation
Based on the gene ontology analysis, we selected 11 genes
with at least one gene being selected from each of the 5
clusters for real-time PCR verification. Four genes, aldose
reductase-like protein, matrix metalloproteinase 2 and 11, and
alanyl membrane aminopeptidase, had little association with
the microarray and were disregarded from further investi-
gation. For the rest of the genes, alkaline phosphodiesterase
(Ap), glycoprotein nonmetastatic melanoma protein B
(Gpnmp), inhibitor of DNA binding 1 (Id1), lactate dehydro-
genase A (Ldha), cytochrome c oxidase 6 a2 (Cox6a2), phos-
phoglycerate kinase (Pgk1), triosephosphate isomerase 1
(Tpi1), 69% of the log2 ratios from the real-time PCR
showed similar trends with the microarray data based on
log2 ratio being positive or negative even though absolute
changes varied (Fig. 5). Differences in the results may be
due to the difference between the two methods. Of these
7 genes, three (Tpi1, Pgk1, and Ldha) were from cluster 5
whose functional category is comprised largely of glycoly-
sis. Two (Ap and Cox6a2) were from cluster 3 whose func-
tional category primarily includes response, proteolysis
and peptidolysis. The remaining two, Id1 and Gpnmb were
in clusters 2 and 4, respectively. All of these genes have
functions directly or indirectly related to metabolism, gly-
colysis and cell proliferation which may associate them
with cell transformation. Table 1 shows the major func-
tions and the cellular locations of these 7 genes.
Discussion and conclusion
Large scale screening of genes involved in the arsenic-
induced alternation of gene expression is a practical
approach for dissecting the molecular pathways of arsenic
toxicity. DNA microarrays are now widely used to study
differential gene expression in relation to arsenic exposure
[11,25-27]. Along with our present study, these previous
studies illustrate that genes identified via microarray in
wide-screening of cells exposed to arsenic can be a valua-
ble tool to determine the mechanism of arsenic toxicity
and cancer formation.
In our study, we used an in-house rat DNA microarray
composed of 6,221 known genes and 3,594 ESTs to inves-
Microarray experimental design Figure 2
Microarray experimental design. A. Loop design used for microarray hybridization study. Each RNA sample was divided 
into 2 parts: one was labeled with Cy3 and the other with Alexa 647. Two cDNAs with different dyes were paired and hybrid-
ized to an array. B. For each paired sample, dye flip was used to overcome the difference between two fluorescent dyes 
because their intrinsic properties. Three cell preparations were used.BMC Genomics 2008, 9:115 http://www.biomedcentral.com/1471-2164/9/115
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Tree view for clustered genes Figure 3
Tree view for clustered genes. K-mean cluster analysis of 131 genes, which were significantly changed between at least 2 
time points as tested by SAM was performed using cluster and TreeView. Genes were clustered into 5 clusters. Each row cor-
responds to one gene, and each column corresponds to log2 ratio. Red = upregulation; green = downregulation; black = no 
change. Brightness of the color represents the value of the ratio. C: control untreated cells; D1-7; the cells treated with 0.75 
µM for 1–7 days.BMC Genomics 2008, 9:115 http://www.biomedcentral.com/1471-2164/9/115
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tigate differential gene expression in arsenic-treated rat
lung cells. This is the first study to focus on arsenic-
induced gene expression alterations in the lung. Global
gene expression patterns were identified by cluster analy-
sis. Because of the notable link between arsenic toxicity
and cancer formation in other organ systems, genes which
have been previously linked with cancer and which may
be important in arsenic toxicity were chosen from the 10
k microarray clusters to be further confirmed via real-time
PCR. Real-time PCR verified 7 genes at a consistency of
69%.
One of the identified genes, Ldha, is involved in glycolysis
in metabolism. Silencing of this gene has been shown to
lead to the increased expression of the Ldhb gene and a
subsequent abnormal expression of lactose dehydrogenase
(LD) [28]. There seems to be a strong correlation between
high LD expression and tumors, which has led to the use
of LD as a marker for cancer [29,30]. Our study shows a
steady decline in the expression of Ldha in response to
arsenic, which may lead to the typical increase in LD seen
in various cancers.
Tpi1 is a glycolytic enzyme found in mitochondria that
catalyzes the reversible interconversion of glyceraldehyde
3-phosphate and dihydroxyacetone phosphate. It plays an
important role in several metabolic pathways including
fatty acid biosynthesis, gluconeogenesis and glycolysis
and is essential for efficient energy production [31]. Tpi1
has exhibited varied expression between different types of
cancer [32] and may play a role in tumor metabolism.
Our study shows a steady decline in the expression of Tpi1
Expression patterns and functional analysis of each cluster from microarray Figure 4
Expression patterns and functional analysis of each cluster from microarray. Fold change over control cells was cal-
culated for each gene. The fold changes of all genes in each cluster identified by K-means clustering analysis were averaged and 
plotted as fold change v.s time. The results shown are means ± S.E. Distribution of major functional categories for biological 
process terms are shown in pie charts. C: control untreated cells; D1-D7; the cells treated with 0.75 µM arsenic for 1–7 days.BMC Genomics 2008, 9:115 http://www.biomedcentral.com/1471-2164/9/115
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Comparison of microarray and real-time PCR Figure 5
Comparison of microarray and real-time PCR. Total RNA was extracted from L2 cells exposed to 0.75 µM arsenic for 
0, 1, 3, 5 and 7 days (C, D1, D3, D5 and D7) and reverse transcribed into cDNA. The mRNA levels were determined by real-
time PCR and the data were normalized to 18S rRNA. Comparison of microarray and real-time PCR data is seen. Values are 
means ± SE; n = 3 cell preparations, each assayed in duplicate. D1/C (1), D3/D1 (2), D5/D3 (3), D7/D5 (4), C/D7 (5).BMC Genomics 2008, 9:115 http://www.biomedcentral.com/1471-2164/9/115
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in arsenic-exposed L2 cells. Further testing will be needed
to determine if this phenomenon is constant among lung
cancers.
Pgk1 is a major enzyme found in mitrochondria. Its func-
tion involves catalyzing the reversible conversion of 1, 3-
diphosphoglycerate to 3-phosphoglycerate, generating
one molecule of ATP. Many studies have reported overex-
pression of Pgk1 in tumors [33-35]. However, a recent
study has linked decreased Pgk1 expression to prostate
tumor [36]. The same study also found that Pgk1 showed
an inverse expression to CXCR4 activation, suggesting that
signaling through the CXCR4 receptor regulates Pgk1 and
vice versa. Our study showed a steady decline in arsenic-
treated L2 cells. Further investigation is needed to deter-
mine the expression of Pgk1 in lung cancers.
Cox6a2 is the third gene investigated that is found in mito-
chondria. It is involved in cytochrome oxidase activity
and is the terminal electron acceptor in the electron trans-
port chain. Through its functions, Cox helps to produce
ATP. One study found that Cox may be related to the pro-
gression of bladder cancer as Cox activities were found to
be increased during and even after the discontinuance of
carcinogen administration in rats [37]. Our study showed
a steady increase in Cox6a2, which correlates with the
increased expression seen in cancers. The location of Tpi1,
Pgk1 and Cox6a2 suggests that mitochondrial DNA may
be specifically targeted by arsenic. It has been shown that
arsenic causes genetic and epigenetic changes [4]. Other
studies have also linked arsenic to mitochondrial DNA
damage, where mitochondrial DNA-depleted cells pro-
duced few or no mutations in response to arsenic expo-
sure compared to intact cells [38,39]. It seems that one
way arsenic confers its carcinogenicity is to simply damage
components of the cellular respiratory machinery to cre-
ate ROS and/or to decrease the cell's defense against ROS.
The unchecked ROS is thus capable of damaging DNA to
the point of inducing transformation.
Id proteins inhibit transcription by binding basic helix-
loop-helix (HLH) transcription factors through their HLH
motif. Id proteins are involved in cell growth, develop-
ment, senescence, differentiation and angiogenesis. Sev-
eral studies have linked Id1  to cancer [40-43].
Furthermore, Id proteins are up-regulated in cancer cells
in response to hypoxia [44], which points to a secondary
role in tumor maintenance as well as carcinogenesis. Our
study showed an initial spike of Id1 expression at day 1
with a steady decline thereafter. The transient expression
may reflect compensatory mechanisms in the L2 cells.
Gpnmb is involved in bone mineralization and osteoblast
differentiation. It was found to be highly expressed in a
low-metastatic human melanoma cell line [45]; however,
our study showed varied expression throughout the time-
points. Gpnmb is a relatively novel gene and more can be
determined about their functions and possible role in car-
cinogenesis with further studies.
In conclusion, through our gene expression profiling of
the L2 cell line exposed to arsenite, we found differentially
expressed genes that may be associated with cancer. Our
findings show that the altered gene expression is a direct
result of arsenic exposure. Our analysis links several of the
identified genes with functions that include cell growth,
cell differentiation and cell metabolism. Information
gained from this work is valuable for the direction of
future experiments involving arsenic toxicity and lung
cancer formation.
Table 1: Function of genes verified via real-time PCR
Gene Name Tissue Major Functions Cellular location
Id1 Mixed tissue DNA binding; development; negative regulation of transcription 
from Pol II promoter; regulation of angiogenesis
Nucleus
Cox6a2 Mixed tissue Cytochrome C oxidase activity: electron transport; 
oxidoreductase activity; respiratory chain complex IV
mitochondrion
Ap Liver Phosphodiesterase activity: catalysis of the reaction; regulate cyclic 
nucleotide signaling; signal transduction regulation; second 
messenger molecules.
Cell and nuclear membrane; subcellular domains
Ldha Mixed tissue L-lactate dehydrogenase activity: glycolysis; lactate dehydrogenase 
activity: oxidoreductase activity
Cytoplasm
Gpnmb Bone bone mineralization; osteoblast differentiation Plasma membrane
Tpi1 Mixed tissue Fatty acid biosynthesis; gluconeogenesis; glycolysis; isomerase 
activity; metabolism; pentose-phosphate shunt; triose-phosphate 
isomerase activity
Mitochondrion
Pgk1 Mixed tissue Glycolysis; kinase activity; phosphoglycerate kinase activity; 
phosphorylase kinase activity; phosphorylase kinase complex; 
transferase activity
MitochondrionBMC Genomics 2008, 9:115 http://www.biomedcentral.com/1471-2164/9/115
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Methods
Materials
The rat lung epithelial cell line L2 (Cat# CCL-149), a clon-
ally isolated cell line from the terminal alveoli of adult
female rats and F12 K medium were purchased from
ATCC (Manassas, VA). Sodium arsenite and 3- [4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) was from Sigma. Fetal bovine serum (FBS), penicil-
lin and streptomycin were from Invitrogen (Carlsbad,
CA). RNase-free DNase was from Ambion Inc. (Austin,
TX) and M-MLV reverse transcriptase was from Invitrogen
(Carlsbad, CA). Tri Reagent was from Molecular Research
Center, Inc. (Cincinnati, OH). The Pan10K rat oligonucle-
otide set was from MWG Biotech. Inc. (High Point, NC).
SYBR Green 1 was from Qiagen (Valencia, CA). Epoxy
glass slides were from CEL Associates (Houston, TX). The
3DNA array 50 kit was from Genesphere (Hatfield, PA).
Microcom YM-30 columns were from Millpore (Billerica,
MA).
Cell culture and exposure
L2 cells (passages 30–40) were cultured in 30 or 100 mm
cell culture dishes in F12 K medium supplemented with
10% of heat-inactivated FBS and antibiotics (1 × penicil-
lin/streptomycin). When grown to 80 to 90% confluence,
the cells were treated with 0–5 µM arsenite for 7 days or
with 0.75 µM arsenite for 1–7 days. The control cells were
the untreated cells at day 0. Three cell preparations (n = 3)
were used for statistical analysis. At the end of incubation,
the cells were used for the viability assay, DNA microarray
analysis and real-time PCR analysis.
Cell viability assay
Cell viability was determined by the MTT assay [46],
which detects mitochondrial dehydrogenase activity.
Cells were seeded onto 35 mm dishes and subsequently
washed twice with phosphate-buffered saline. One ml of
0.5 mg/ml of MTT was then added to the dishes. After 2 h
incubation at 37°C, the solution was carefully removed
and 2 ml of dimethylsulfoxide added. The dishes were
placed on a shaker for 10 min. The absorbance at 485 nm
of the resulting solution was measured.
RNA extraction
Total RNA was separately isolated from 3 cell preparations
of the control and arsenic-treated cells using TRI REA-
GENT per the manufacturer's protocol (Molecular
Research Ceneter, Inc, Cincinnati, OH). The cultured L2
cells in 100 mm dishes were washed three times with
phosphate-buffered prior to the extraction. One ml of TRI
REAGENT was added to L2 cells, followed by 0.1 ml of 1-
bromo-3-chloropropane. After 2–15 min, the mixture was
centrifuged at 12,000 g for 15 min at 4°C. RNA in the
aqueous phase was precipitated with 0.5 ml isopropanol,
washed with 1 ml of 75% ethanol, and resuspended in
RNase-free water. RNA concentration was determined by
a spectrophotometer (NanoDrop Technologies, Rock-
land, DE). RNA quality was assessed for integrity by visual
evaluation of 28S and 18S rRNA bands on an agarose gel
and by measurement of the absorbance at 260 nm and
280 nm.
DNA microarray printing
We printed 10 K rat oligonucleotides (oligos) as previ-
ously described [47]. The oligos represent 6,221 known
genes, 3,594 EST and 169 Arabidopsis negative controls.
Each oligo was spotted in triplicate on three identical 18 ×
18 mm blocks in one slide. The spot-spot distance was
160 µm and the space between blocks was 4 mm. Each
block consists of 16 subarrays and can be used as an indi-
vidual slide or replicate. Oligos (25 µM) were amino-
modified and resuspended in 3 × SSC printing buffer, and
arrayed from 26 384-well microplates onto Epoxy glass
slides using an OminiGrid 100 arrayer (GeneMachine,
San Carlos, CA). To immobilize oligos, the slides were
incubated for 2 days at room temperature and 65%
humidity, washed one time with 0.2% SDS for 2 min and
then 3 times with ddH2O. Finally, slides were incubated
in ddH2O for 20 min at 50°C. Printing spots were uni-
form as assessed by SYTO-6 staining.
DNA microarray hybridization
There were total 3 cell preparations treated with arsenite.
Each sample was arranged for hybridizations in a loop
style (Fig. 2A). Dye flip was performed (Fig. 2B). Total
number of hybridization for each sample was 12 (3 for
cell preparations, 2 for loop-design and 2 for dye flip).
There were 30 hybridizations for the whole experiment (3
cell preparations, dye flip, and 5 samples). Total RNA (10
µg) from each sample was split into two aliquots and each
was reverse-transcribed into cDNA using Cy3 or Alexa
Fluro 647-specific primers provided with the Genesphere
kit 3DNA array 50 kit. The cDNAs were column-purified,
quantified by a NanoDrop spectrophometer, adjusted to
0.5 µg/µl and mixed with 2× formamide hybridization
buffer (50% formamide, 6 × SSC, 0.2% SDS) in equal vol-
ume. The paired cDNAs were then combined in a 1:1 ratio
(v/v) and denatured at 80°C for 10 min. The slide was
blocked with 0.1% SDS, 1% BSA and 3 × SSC at 42°C for
40 min and hybridized with labeled cDNAs at 45°C for 48
h. The slide was then washed and incubated with Cy-3 or
Alexa 647-labeled dendrimers at 45°C for 3 h. After being
washing, the slide was scanned using a ScanArray Express
laser scanner (PerkinElmer, Boston, MA).
DNA microarray data analysis
The scanned images were analyzed with GenePix pro 4
(Axon Instruments, Inc, Union City, CA). The raw data
were subjected to quality controls using our in-house soft-
ware, RealSpot [48]. This software automatically assigns aBMC Genomics 2008, 9:115 http://www.biomedcentral.com/1471-2164/9/115
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quality index to each spot based on fluorescence intensity
and signal-to-background ratio (SBR). We set 2 as the SBR
cut-off value. We filtered data with an average quality
index of < 1 for all time points. Log2 ratios were then cal-
culated from background-subtracted signal mean inten-
sity and were normalized with the LOWESS
normalization method. We then performed statistical
analysis using the significant analysis of microarray
(SAM) package [49]. The q-value was set at 0.05. Finally,
K-mean cluster analysis was performed using Cluster and
TreeView programs [50]. The microarray dataset was
deposited to GEO (access number GSE 9790) [51].
Real-time PCR
Gene verification at the mRNA level was obtained using
real-time PCR on RNA samples from arsenic-treated L2
cells which were exposed for 0, 1, 3, 5 and 7 days. Total
RNA was treated with RNase-free DNase to remove DNA
contamination and then reverse-transcribed into cDNA
using random hexamers and M-MLV reverse transcriptase.
The real-time PCR primers were designed using Primer
Express software (Applied Biosystems, Foster City, CA).
The length of each primer was kept between the lengths of
20–25 bp with a Tm of 58–60°C (Table 2). The specificity
of the primers was confirmed using the BLAST search. The
real-time PCR was performed on an ABI 7500 system
using a SYBR Green 1 for detection. The thermal condi-
tions included a heat activation of the DNA polymerase at
95°C for 15 min, followed by 40 cycles of denaturing at
95°C for 20 s, annealing at 60°C for 30 s, extension at
72°C for 30 s. After the amplification, a dissociation curve
was generated for each gene to check the specificity of the
PCR products. The relative abundance of each gene was
calculated by subtracting the CT value of each sample of an
individual gene from the corresponding value for the 18 S
gene based on the ∆ Ct method [52].
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